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Background: Ex situ donor liver machine perfusion is a promising tool to assess
organ viability prior to transplantation and platform to investigate novel therapeutic
interventions. However, the wide variability in donor and graft characteristics between
individual donor livers limits the comparability of results. We investigated the hypothesis
that the development of a split liver ex situ machine perfusion protocol provides the
ideal comparative controls in the investigation of machine perfusion techniques and
therapeutic interventions, thus leading to more comparable results.
Methods: Four discarded human donor livers were surgically split following identification
and separation of right and left inflow and outflow vessels. Each lobe, on separate
perfusion machines, was subjected to normothermic perfusion using an artificial
hemoglobin-based oxygen carrier solution for 6 h. Metabolic parameters as well as
hepatic artery and portal vein perfusion parameters monitored.
Results: Trends in hepatic artery and portal vein flows showed a general increase in both
lobes throughout each perfusion experiment, even when normalized for tissue weight.
Progressive decreases in perfusate lactate and glucose levels exhibited comparable
trends in between lobes.
Conclusion: Our results demonstrate comparability between right and left lobes
when simultaneously subjected to normothermic machine perfusion. In the pre-clinical
setting, this model provides the ideal comparative controls in the investigation of
therapeutic interventions.
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INTRODUCTION
The main purpose of ex situ donor liver machine perfusion
has been the development of superior modality of organ
preservation to conventional static cold storage as well as
a method to assess organ viability prior to transplantation
(1). In the United Kingdom, between April 2018 and March
2019, 15% of donor livers retrieved were not transplanted,
representing a significant pool of potentially viable grafts (2)
A recent randomized controlled clinical trial demonstrated that
normothermic machine liver perfusion (NMLP) reduced discard
rates of donor organs when compared to static cold storage,
without jeopardizing transplant outcomes (3, 4). A number
of perfusion devices are currently available. The principal
components include a blood reservoir, centrifugal pump, oxygen
concentrator, heat exchanger and a circuit which continuously
pumps perfusate through the liver via the organ’s inflow vessels
(hepatic artery and/or portal vein) and recirculates this following
drainage from the inferior vena cava (1). These systems allow
for extraction of perfusate for blood gas analysis, thus enabling
real-time monitoring of oxygen and carbon dioxide levels,
acid-base homeostasis as well as glucose levels (1) All these
parameters have been described as markers for organ viability
during machine perfusion (5). Several pre-clinical and clinical
non-randomized studies have investigated different perfusion
modalities with variations in perfusion temperature, perfusate
composition, perfusion duration, vessel cannulation as well as
other technical considerations (1).
The technology provides a unique opportunity for assessing
liver metabolic and synthetic function. This has been recognized
by pre-clinical studies investigating the effect of novel therapeutic
interventions on machine perfused donor livers (6, 7). However,
donor livers available for research in machine perfusion have
been, so far, in short supply. Furthermore, the inherent variation
in donor characteristics and liver quality that exist between
different livers have limited their capacity as suitable comparative
controls and, therefore, the interpretability of data from small
series of whole organ perfusions (8).
Splitting of the donor liver is a well-established strategy
used in transplantation to increase organ availability by
allowing the same organ to be “shared” between two recipients
(9). The surgical technique splits the donor organ into
two separate independently-functioning units (9). A pre-
clinical study by Huang et al. reported that, during ex situ
subnormothermic machine perfusion, split livers demonstrated
comparable perfusion and functional characteristics, providing
a controlled comparison between split lobes, thus allowing each
liver to act as its own internal control (10). However, this has yet
to be demonstrated in a normothermicmachine perfusionmodel.
NMLP has been shown to enable the functional assessment and
Abbreviations: BD, Bile duct; DBD, Donor after Brainstem Death; DCD, Donor
after Cardiac Death; CHA, CommonHepatic Artery; LHV, Left Hepatic Vein; LPV,
Left Branch of Portal Vein; LL, Left Lobe; MHV, Middle Hepatic Vein; NHSBT,
National Health Service Blood and Transplant; NMLP, Normothermic Machine
Liver Perfusion; PAS, Periodic Acid Schiff; PV, Portal Vein; RHA, Right Hepatic
Artery; RHV, Right Hepatic Vein; RL, Right Lobe; RPV, Right Branch of Portal
Vein; T0, Start of Perfusion; T6, End of Perfusion after 6 h; VC, Vena Cava.
viability testing of donor livers prior to transplantation in a near-
physiological environment (5, 11). In the context of scientific
research, this makes NMLP a promising pre-clinical platform
for the investigation of therapeutics and mechanistic studies. We
therefore sought to develop a normothermic machine perfusion
protocol for the application of the split liver model to pre-
clinical research. Our hypothesis was that individual lobes from
the same liver would recover and function similarly to one
another when subjected to ex situ end-ischaemic NMLP. In
addition to providing more liver units for perfusion experiments,
the protocol enables each liver to act as its own internal




This study was designed to investigate and compare the
performance of right and left lobes from the same human
liver. Each lobe has their own inflow and outflow vessels as
well as bile drainage, during ex situ end-ischaemic NMLP on
separate perfusion devices, thereby demonstrating their suitable
utilization as comparative controls in the pre-clinical setting.
The primary endpoints were assessment of liver function and
evaluation of perfusion parameters. The perfusionmachines used
for this study both were Liver Assist devices (Organ Assist,
Groningen, The Netherlands).
Donor Liver Source and Selection
Four donor livers were included in this study, resulting in
a total of eight perfusions. All donor livers included in this
study were originally retrieved with the primary intention
for transplantation as per the policy of the National Health
Service Blood and Transplant (NHSBT). The organs were
subsequently rejected for transplantation by all UK liver
transplant centers and, following that, were offered nationally
for research by NHSBT. The authors had no influence in
the process of declining donor livers. This was done by the
transplant surgeons at each center. Informed consent for research
use of donor organs was obtained by specialist nurses in
organ donation from the donor’s next of kin during informed
consent for organ donation. Authorisation for research was
mediated by each centre’s specialist nurse in organ donation.
All methods described were performed in accordance with
NHSBT guidelines and regulations. Study ethical approval was
obtained from the London-Surrey Borders National Research
Ethics Service (Reference Number 13/LO/1926) and the NHSBT
ethics committee (Reference Number 06/Q702/61). No organs
used in this study originated from executed prisoners.
Donor liver exclusion criteria for this study were: gross
macroscopic appearance indicative of moderate or severe
steatosis; asymmetric or poor perfusion demonstrated during
organ retrieval; presence of hepatic malignancy; organ subjected
to machine perfusion prior to being discarded.
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Liver Splitting Protocol
During transportation to our center, the organs were preserved
in University of Wisconsin fluid at hypothermic temperatures in
ice as per current standard clinical practice for static cold storage
in the United Kingdom. Donor livers were split while in cold
storage prior to commencement of perfusion in order to ensure
that both lobes were subjected to similar ischaemic times and
assessed simultaneously when placed in the perfusion devices.
Upon receipt by our center, the liver was initially cleared of excess
tissue in order to assess the quality of the organ. This also allowed
for assessment of the organ’s outflow, with respect to the hepatic
veins and post-hepatic inferior vena cava, as well as the inflow, in
terms of the hepatic arterial tree and portal vein (Figure 1). Since
the perfusion device allows for open drainage of the perfusate
from the organ’s outflow via the post-hepatic inferior vena cava,
the latter was incised in order to create two separate patches
with direct visualization of left, middle and right hepatic veins
(Figure 1). This was the first step in determining the line of
demarcation for parenchymal division. For the purposes of this
study, we sought to divide right and left halves of the liver along
Cantlie’s line—an extrapolated line, used when planning right or
left hepatectomies (liver resections), extending from the middle
of the post-hepatic inferior vena cava across the diaphragmatic
(superior) surface of the liver to the point where the fundus of the
gallbladder on the inferior surface typically contacts the antero-
inferior margin of the liver (Figure 2). This approximates the
plane of the middle hepatic vein and demarcates the right and
left lobes of the liver.
Once the vena cava was opened, the liver hilum was cleared
further of excess tissue in order to identify the left and right
branches of the portal vein and hepatic artery, respectively
(Figure 1). Particular attention was paid to identification of
the arterial branch supplying segment 4 of the liver as this
would influence the level of division of the branches during
splitting. The left and right hepatic ducts were also identified
to ensure that each half would have adequate biliary drainage
(Figure 1). A cholecystectomy was performed, and the cystic
duct identified and ligated. Following satisfactory identification
of all relevant anatomy, the vessels and bile duct were divided
as follows. The hepatic arterial tree was divided such that the
main trunk was retained by the left lobe of the liver with the right
lobe keeping the right hepatic branch, anatomy-permitting. The
right lobe retained the main trunks of the portal vein and bile
duct with the left halve keeping its respective branches. At this
point, parenchymal division was performed and completed along
Cantlie’s line (Figure 2).
If vessel length and diameter was deemed to be inadequate
for safe cannulation of either lobe, particularly with respect to
the isolated branches, then a decision was made to reconstruct
the vessels to enable proper positioning of the cannulas for
perfusion. This was done by fashioning a conduit using native
vessels for extra length in one of two ways: (1) resecting the
distal portion of the main arterial or venous trunk retained by
either lobe, which was then anastomosed onto the branch of
the other; (2) utilizing the length of donor iliac vessels for the
reconstruction (received with the donor liver for the purposes
of arterial or venous reconstruction if required in the setting of
transplantation) (Figure 2). Which technique was adopted was
dependent on the conduit length required as well as the caliber
of the vessels to be anastomosed together. The hepatic arteries
were cannulated with 10−14 F cannulas. Each portal vein was
cannulated with a 24 F cannula.
Ex-situ Perfusion Protocol
Both perfusion devices were primed with our previously
described (12) perfusion protocol using Hemopure [HBOC-201,
hemoglobin glutamer-250 (bovine); HBOC-201, Hemoglobin
Oxygen Therapeutics LLC, Cambridge, MA] instead of packed
red blood cells as the oxygen carrier (Supplementary Material).
The former is a polymerised bovine hemoglobin-based acellular
oxygen carrier of low immunogenicity and an oxygen-carrying
capacity similar to that of human hemoglobin at normothermic
temperatures. Its efficacy as an alternative to blood-based
machine perfusion fluid has been demonstrated in pre-clinical
and clinical studies (12, 13).
The pre-perfusion weight of each lobe was recorded post-
splitting. The arterial and portal venous supplies were cannulated
with each lobe positioned inside the organ reservoir such that
the open drainage from the hepatic veins could be visualized
directly. Perfusion was commenced at 36–37◦C with oxygenated
pulsatile flow and non-pulsatile flow in the hepatic artery
and PV, respectively. Perfusion of each lobe was commenced
within five to 15min of each other (Figure 3). Perfusion
pressures and flow parameters were monitored continuously. An
epoprostenol infusion pump was connected to each perfusion
circuit and commenced at an initial rate of 4 ml/h. The
rate of prostaglandin infusion was adjusted according to the
flow readings to maintain physiological parameters. Hepatic
artery pressures were maintained at 60–70mm Hg while portal
vein pressures were maintained at 10 mmHg. Oxygen supply
was adjusted in order to maintain a perfusate oxygen partial
pressure >10 kPa in the arterial circuit. Serial perfusate samples
were analyzed in real-time using the Cobas b 221 point of
care system (Roche Diagnostics, USA) Blood Gas Analyser in
order to monitor metabolic parameters including oxygen partial
pressures, lactate and glucose levels. These parameters have been
previously described as appropriate methods of monitoring liver
function and viability during the perfusion process (5). Each lobe
underwent NMLP for a total of 6 h. For histological analysis, core
needle biopsies from each lobe were obtained at the beginning
and end of perfusion, fixed in formalin and embedded in paraffin.
These biopsies were subsequently stained with haematoxylin
and eosin for conventional examination and periodic acid schiff
(PAS) for glycogen content and distribution.
Statistical Analysis
Data analysis was carried out using Prism 7 (GraphPad Inc.,
CA). Continuous data at each timepoint was compared using
Wilcoxon signed-rank test. Statistical significance was set at
p<0.05. Data is presented as per lobar mass as well as following
normalization of pre-perfusion lobar weight per gram of tissue.
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FIGURE 1 | Liver Splitting Procedure: (A) Inspection of liver hilum (B) Opening inferior vena cava to identify hepatic venous drainage (C) Identification of portal vein
branches (D) Identification of hepatic arterial branches and hepatic duct transection. BD, bile duct; CHA, common hepatic artery; LHV, left hepatic vein; LL, left lobe;
MHV, middle hepatic vein; PV, portal vein; RL, right lobe; RHV, right hepatic vein; VC, vena cava.
RESULTS
Donor Liver Characteristics
Four livers were included in the study. Information relating to
donor characteristics and liver characteristics can be found in
(Table 1). Right lobe mass was consistently significantly higher
than their left lobe counterparts.
Assessment of Liver Function
Lactate levels were comparable at the start of perfusion, T0,
and decreased significantly in all lobes up until the end of the
perfusion experiment, T6 (Figure 4). Trends in perfusate lactate
clearance were similar in both lobes. When normalized for pre-
perfusion tissue weight, perfusate lactate levels tended to be
higher in the left lobe. However, the rate of reduction in lactate
levels was observed to be similar in both lobes across all perfusion
experiments. Interestingly, in two of the four livers, an increase in
perfusate lactate was observed in both lobes at the same timepoint
during the perfusion experiment. Perfusate glucose levels were
initially high and trended downwards during the course of the
experiment. Lactate and glucose levels were comparable at all
timepoints (Figure 4).
Perfusion Hemodynamics
Hepatic artery and portal venous flows were relatively consistent
in both left and right lobes with a trend toward an increase
in flow rate as the perfusion experiment progressed (Figure 5).
Differences in flow rates for hepatic artery and portal vein were
statistically insignificant across all time points.
Liver Histology
Overall histological analysis showed that both liver lobes
behaved in a similar manner throughout the perfusions. Lobar
architecture was well-preserved in both pre- and post-perfusion
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FIGURE 2 | Liver Splitting Procedure: (A) Parenchymal transection across gallbladder bed (B) Parenchymal transection complete (C) Reconstruction of hepatic artery
using donor celiac artery trunk (D) Cannulation of hepatic artery and portal vein branches. CHA, common hepatic artery; LPV, left portal vein; PV, portal vein; RHA,
right hepatic artery.
biopsies. Some variable centrilobular necrosis was observed at
both time points. However, this was present to the same degree
before and during NMLP. All biopsies were PAS positive with
staining showing a range of intensity from mild to strong and
ranging from even distribution throughout the parenchyma to
patchy. Whatever the variability between liver, each of the paired
lobes showed strong similarity, with no change throughout the
perfusion. In addition, patterns of histology did not correlate with
any parameters of functional assessment. Only one liver showed
evidence of significant macrovesicular steatosis which did not
change between lobes or throughout the perfusion (Figure 6).
DISCUSSION
Several studies have demonstrated that NMLP enables the
functional recovery of discarded donor livers and provides
a window of opportunity for viability assessment prior to
transplantation. However, results are compounded by small
sample size as a consequence of the limited availability of
discarded donor livers for research, further compounded by
the inherent differences between donor livers. This limits
comparability between groups of individual livers.
Splitting of the donor liver is a well-known procedure in liver
transplantation to optimize the use of grafts (9). Human split liver
machine perfusion data in the normothermic setting is limited
to case reports (14, 15). With this in mind, we sought to adapt
the split liver technique to the normothermic machine perfusion
model with the aim of providing a more robust perfusion
protocol with each liver providing its own internal control. Our
results show that split livers recover functionality and perform
similarly to each other when subjected NMLP. The development
of a split liver model to ex situ end-ischaemic NMLP, therefore,
has the potential to provide a platform for suitable comparative
controls for the investigation and assessment of therapeutic
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FIGURE 3 | Split lobe perfusion: (A) Left lobe (B) Right lobe. CHA, common hepatic artery; LPV, left portal vein; MHV, middle hepatic vein; PV, portal vein; RHA, right
hepatic artery; RPV, right portal vein.
TABLE 1 | Donor liver demographics and characteristics.
Liver 1 Liver 2 Liver 3 Liver 4
Donor age (years) 31 75 57 73
Gender Male Male Female Female
DBD/DCD DCD DBD DCD DBD
Cold ischaemia time (min) 902 799 1,108 1,026
Weight (g)
Right lobe 715 1,120 957 739
Left lobe 488 851 851 363
DBD, donor after brainstem death; DCD, donor after cardiac death.
interventions prior to being subjected to the rigor of a clinical
trial. Research published previously by our group allowed for
an initial four-hour window of NMLP before a full viability
assessment of the perfused organ is carried out (11). This period
is important in the setting of split liver machine perfusion for
two reasons. First and foremost, it will allow for the functional
recovery of both lobes following a variable period of cold
ischaemia. Secondly, it will enable the investigator to assess and
monitor differences in the parameters and performance of the
two lobes prior to therapeutic intervention.
The model described in the paper was developed solely
for experimental purposes without considerations for clinical
adoption. The inflow portal venous anatomy was without
variations which allowed us to develop a standardized
approached used in all livers. As the outflow from the liver
was on free drainage to the reservoir, the site of caval division
did not have any impact on function. In view of the open circuit
perfusion system, the liver outflow veins (including segmental
veins draining into the middle hepatic vein) did not require any
reconstruction as the blood was freely drained and collected in
the device reservoir. As such, hepatic veins anatomy and inferior
vena cava accessories did not influence the surgical technique or
the perfusion parameters. The situation would be different if a
closed circuit was being used or if clinical use of these segmental
grafts was under consideration.
The incorporation of NMLP to the split liver model has
the benefit of enabling liver functional assessment under near-
physiological conditions. The use of an artificial acellular
hemoglobin-based perfusion fluid also has its advantages. Unlike
blood products (derived from various donors), it has low
immunogenicity and may therefore be of greater value in the
study of liver-specific immune cell populations and mechanistic
studies (12). Secondly, while the utility of blood products
as perfusion fluid is limited to physiological temperatures,
Hemopure can be deployed as a perfusion fluid under
hypothermic conditions (12). Subsequently, our proposed split
liver model can be applied to a range of perfusion temperatures.
It must be noted that there are limitations to the design
of this perfusion model. First, splitting of the liver requires
considerable surgical expertise and increases the cold ischaemia
time beyond what is usual for the preparation of a whole liver
for machine perfusion. Secondly, due to the liver’s anatomy, the
right lobe is invariably larger than the left lobe and therefore they
cannot be split into entities of equal mass without compromising
blood supply. Furthermore, the shorter and smaller caliber of
hepatic artery and portal vein branches makes them much
more difficult to cannulate. We attempted to circumvent this
issue by retaining the main trunk of the vessel with one lobe
while performing vascular reconstructions on the other, using
donor iliac vessels or larger caliber sections from the proximal
celiac trunk or splenic artery (if included in the specimen).
In all experiments this provided the additional length for safe
cannulation. However, this technique further increases the cold
ischaemia time of the liver and would also require the appropriate
surgical expertise for a robust reconstruction that would not
compromise lobar perfusion. All these aforementioned factors
may lead to differences in the perfusion characteristics of each
lobe and must be considered. Finally, not all livers can be split.
This is often a result of variations in arterial anatomy due to
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FIGURE 4 | Perfusate lactate (A) and glucose (B) levels for each individual split lobe over 6 h of end-ischaemic normothermic machine perfusion.
FIGURE 5 | Hepatic artery (A) and portal vein (B) flows for each individual split lobe over 6 h of end-ischaemic normothermic machine perfusion.
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FIGURE 6 | PAS staining from two representative perfusion experiments. (A) (from liver case number 2) shows mild to moderate macrovesicular steatosis, portal
inflammatory cell infiltration and patchy PAS staining which was the same at commencement and end of perfusion. (B) (from liver case number 4) shows a liver with
evenly distributed PAS staining throughout. Again, a degree of portal inflammation was seen. T0: pre-perfusion, T6: end of perfusion.
branching patterns which would compromise the inflow of a
segment of the lobe if divided.
We acknowledge that the data presented in this manuscript
is from a small number of human donor livers. Nevertheless,
the results of this proof-of-concept study indicate that trends
in the functional recovery and metabolic parameters between
lobes were very similar and may therefore prove useful in the
assessment of responses to therapeutic interventions in the pre-
clinical normothermic setting. Additionally, this model addresses
the variability that exists between individual donor livers by
enabling the same donor liver to be placed in the treatment
and control groups. This also maximizes use of resources as one
donor liver for pre-clinical studies.
Other benefits observed during these experiments came
from the use of a perfusion machine with an open circuit.
These included: facilitated manipulation of the graft for direct
visualization, direct visualization of and access to graft outflow
and superior access to graft for direct therapeutic interventions
when compared to closed circuit alternatives.
CONCLUSION
Liver splitting is a feasible model for providing comparative
controls for pre-clinical normothermic machine perfusion
research. Further work should involve the optimisation of this
protocol to minimize the need for surgical expertise when
preparing the liver formachine perfusion as well as its application
to other perfusion modalities, namely, hypothermic and sub-
normothermic perfusion. This novel split liver model can be
tested for cellular therapies to investigated cellular phenotype
and lineage changes and future pharmacological interventions of
donor liver before implantation.
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